Numerous variations to a manufacturing process may take place during the life cycle of a vaccine. To support these variations, the regulator requires providing stability data according to the existing ICH guidelines; these have been designed for documenting the licence of a new vaccine. Comparative studies and adapted stability designs specific to the variation will give far more confidence to the manufacturer and the regulator than the classical model. The following case study applied to a change of a stopper illustrates this approach.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.biologicals.2009.08.006 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!